- Home
- ANTA vs THRD Comparison
ANTA vs THRD Comparison
Compare ANTA & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTA
- THRD
- Stock Information
- Founded
- ANTA 2022
- THRD 2019
- Country
- ANTA Singapore
- THRD United States
- Employees
- ANTA N/A
- THRD N/A
- Industry
- ANTA Investment Bankers/Brokers/Service
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- ANTA Finance
- THRD Health Care
- Exchange
- ANTA Nasdaq
- THRD Nasdaq
- Market Cap
- ANTA 258.7M
- THRD 232.4M
- IPO Year
- ANTA 2025
- THRD 2022
- Fundamental
- Price
- ANTA $13.88
- THRD $5.25
- Analyst Decision
- ANTA
- THRD Hold
- Analyst Count
- ANTA 0
- THRD 3
- Target Price
- ANTA N/A
- THRD $5.00
- AVG Volume (30 Days)
- ANTA 692.4K
- THRD 296.2K
- Earning Date
- ANTA 01-01-0001
- THRD 05-08-2025
- Dividend Yield
- ANTA N/A
- THRD N/A
- EPS Growth
- ANTA N/A
- THRD N/A
- EPS
- ANTA 0.23
- THRD N/A
- Revenue
- ANTA $47,454,993.00
- THRD N/A
- Revenue This Year
- ANTA N/A
- THRD N/A
- Revenue Next Year
- ANTA N/A
- THRD N/A
- P/E Ratio
- ANTA $55.43
- THRD N/A
- Revenue Growth
- ANTA 320.96
- THRD N/A
- 52 Week Low
- ANTA $10.19
- THRD $3.18
- 52 Week High
- ANTA $27.72
- THRD $16.02
- Technical
- Relative Strength Index (RSI)
- ANTA N/A
- THRD 75.64
- Support Level
- ANTA N/A
- THRD $5.16
- Resistance Level
- ANTA N/A
- THRD $5.22
- Average True Range (ATR)
- ANTA 0.00
- THRD 0.04
- MACD
- ANTA 0.00
- THRD -0.03
- Stochastic Oscillator
- ANTA 0.00
- THRD 100.00
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.